Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-25-001826
Filing Date
2025-02-27
Accepted
2025-02-27 16:43:42
Documents
111
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K gpcr-20241231x10k.htm   iXBRL 10-K 3280701
2 EX-10.19 gpcr-20241231xex10d19.htm EX-10.19 20170
3 EX-19.1 gpcr-20241231xex19d1.htm EX-19.1 129720
4 EX-23.1 gpcr-20241231xex23d1.htm EX-23.1 5089
5 EX-31.1 gpcr-20241231xex31d1.htm EX-31.1 20660
6 EX-31.2 gpcr-20241231xex31d2.htm EX-31.2 20751
7 EX-32.1 gpcr-20241231xex32d1.htm EX-32.1 12123
8 EX-32.2 gpcr-20241231xex32d2.htm EX-32.2 12392
9 GRAPHIC gpcr-20241231x10k001.jpg GRAPHIC 87335
10 GRAPHIC gpcr-20241231x10k002.jpg GRAPHIC 48363
11 GRAPHIC gpcr-20241231x10k003.jpg GRAPHIC 53255
12 GRAPHIC gpcr-20241231x10k004.jpg GRAPHIC 86761
13 GRAPHIC gpcr-20241231x10k005.jpg GRAPHIC 55258
14 GRAPHIC gpcr-20241231x10k006.jpg GRAPHIC 99049
15 GRAPHIC gpcr-20241231x10k007.jpg GRAPHIC 72279
16 GRAPHIC gpcr-20241231x10k008.jpg GRAPHIC 47786
17 GRAPHIC gpcr-20241231x10k009.jpg GRAPHIC 65224
18 GRAPHIC gpcr-20241231x10k010.jpg GRAPHIC 68729
19 GRAPHIC gpcr-20241231x10k011.jpg GRAPHIC 80678
20 GRAPHIC gpcr-20241231x10k012.jpg GRAPHIC 35384
21 GRAPHIC gpcr-20241231x10k013.jpg GRAPHIC 82646
22 GRAPHIC gpcr-20241231x10k014.jpg GRAPHIC 82487
23 GRAPHIC gpcr-20241231x10k015.jpg GRAPHIC 71181
24 GRAPHIC gpcr-20241231x10k016.jpg GRAPHIC 44737
25 GRAPHIC gpcr-20241231x10k017.jpg GRAPHIC 45712
26 GRAPHIC gpcr-20241231x10k018.jpg GRAPHIC 94664
27 GRAPHIC gpcr-20241231x10k019.jpg GRAPHIC 47451
28 GRAPHIC gpcr-20241231x10k020.jpg GRAPHIC 50952
29 GRAPHIC gpcr-20241231x10k021.jpg GRAPHIC 47233
30 GRAPHIC gpcr-20241231x10k022.jpg GRAPHIC 46339
31 GRAPHIC gpcr-20241231x10k023.jpg GRAPHIC 34172
32 GRAPHIC gpcr-20241231x10k024.jpg GRAPHIC 95624
33 GRAPHIC gpcr-20241231x10k025.jpg GRAPHIC 41660
34 GRAPHIC gpcr-20241231x10k026.jpg GRAPHIC 89628
35 GRAPHIC gpcr-20241231x10k027.jpg GRAPHIC 76039
36 GRAPHIC gpcr-20241231x10k028.jpg GRAPHIC 56299
37 GRAPHIC gpcr-20241231x10k029.jpg GRAPHIC 133059
38 GRAPHIC gpcr-20241231x10k030.jpg GRAPHIC 112893
  Complete submission text file 0001558370-25-001826.txt   16836254

Data Files

Seq Description Document Type Size
39 EX-101.SCH gpcr-20241231.xsd EX-101.SCH 60090
40 EX-101.CAL gpcr-20241231_cal.xml EX-101.CAL 70387
41 EX-101.DEF gpcr-20241231_def.xml EX-101.DEF 258832
42 EX-101.LAB gpcr-20241231_lab.xml EX-101.LAB 600392
43 EX-101.PRE gpcr-20241231_pre.xml EX-101.PRE 462627
114 EXTRACTED XBRL INSTANCE DOCUMENT gpcr-20241231x10k_htm.xml XML 1794041
Mailing Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080 (628) 229-9277
Structure Therapeutics Inc. (Filer) CIK: 0001888886 (see all company filings)

EIN.: 981480821 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41608 | Film No.: 25679970
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)